Growth Metrics

Maravai Lifesciences Holdings (MRVI) Capital Leases (2020 - 2025)

Maravai Lifesciences Holdings has reported Capital Leases over the past 5 years, most recently at $30.1 million for Q4 2025.

  • Quarterly results put Capital Leases at $30.1 million for Q4 2025, down 3.1% from a year ago — trailing twelve months through Dec 2025 was $30.1 million (down 3.1% YoY), and the annual figure for FY2025 was $30.1 million, down 3.1%.
  • Capital Leases for Q4 2025 was $30.1 million at Maravai Lifesciences Holdings, down from $30.4 million in the prior quarter.
  • Over the last five years, Capital Leases for MRVI hit a ceiling of $55.9 million in Q1 2021 and a floor of $16.6 million in Q1 2023.
  • Median Capital Leases over the past 4 years was $31.5 million (2024), compared with a mean of $35.2 million.
  • Biggest five-year swings in Capital Leases: skyrocketed 91.41% in 2024 and later dropped 3.1% in 2025.
  • Maravai Lifesciences Holdings' Capital Leases stood at $55.3 million in 2021, then tumbled by 42.35% to $31.9 million in 2023, then fell by 2.48% to $31.1 million in 2024, then dropped by 3.1% to $30.1 million in 2025.
  • The last three reported values for Capital Leases were $30.1 million (Q4 2025), $30.4 million (Q3 2025), and $30.7 million (Q2 2025) per Business Quant data.